SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 93 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 93 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.7% | 93 | -99.7% | 0.00% | -100.0% |
| Q3 2021 | $329,000 | -30.0% | 36,537 | -6.9% | 0.01% | -33.3% |
| Q2 2021 | $470,000 | -7.8% | 39,250 | -3.5% | 0.02% | -19.2% |
| Q1 2021 | $510,000 | -33.3% | 40,694 | -17.0% | 0.03% | -38.1% |
| Q4 2020 | $765,000 | +252.5% | 49,039 | +113.7% | 0.04% | +200.0% |
| Q3 2020 | $217,000 | +6.9% | 22,951 | +1.2% | 0.01% | -6.7% |
| Q2 2020 | $203,000 | +55.0% | 22,668 | +10.6% | 0.02% | +36.4% |
| Q1 2020 | $131,000 | -30.3% | 20,490 | -8.8% | 0.01% | -15.4% |
| Q4 2019 | $188,000 | – | 22,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |